Stenotrophomonas maltophilia meningitis treated with moxifloxacin: A case report and review of the literature

Infectious Diseases in Clinical Practice

Volumn 14, Issue 3, 2006, Pages 173-176

  Reddy, Pavani ^a,b   Das, Sunit ^a   Chandler, James P ^a   Noskin, Gary A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL MENINGITIS; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID FISTULA; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DRUG HYPERSENSITIVITY; GRAM STAINING; HOSPITAL INFECTION; HUMAN; HYPOPHYSIS ADENOMA; MACULOPAPULAR RASH; MALE; PNEUMOCEPHALUS; PNEUMONIA; STENOTROPHOMONAS MALTOPHILIA; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR RECURRENCE;

EID: 33744499700     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000194059.14537.e5     Document Type: Article

References (25)

1. Zuravleff JJ, Yu VL. Infections caused by Pseudomonas maltophilia with an emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis. 1982;4(6):1236-1246.
2. Trump DL, Grossman SA, Thompson G, et al. CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy. Arch Intern Med. 1982;142(3):583-586.
3. Muder RR, Yu VL, Dummer JS, et al. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med. 1987;147(9):1672- 1674.
4. Girijaratnakumari T, Raja A, Ramani R, et al. Meningitis due to Xanthomonas maltophilia. J Postgrad Med. 1993;39(3):153-155.
5. Nguyen MH, Muder RR. Meningitis due to Xanthomonas maltophilia: case report and review. Clin Infect Dis. 1994;19(2):325-326.
6. Papadakis KA, Vartivarian SE, Vassilaki ME, et al. Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature. J Neurosurg. 1997;87(1):106-108.
7. Platsouka E, Routsi C, Chalkis A, et al. Stenotrophomonas maltophilia meningitis, bacteremia and respiratory infection. Scand J Infect Dis. 2002;34(5):391-392.
8. Lozier A, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170-181.
9. Lyke KE, Obasanjo OO, Williams MA, et al. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33(12):2028-2033.
10. Alleyne CH Jr, Hassan M, Zabramski JM. The efficacy and cost of prophylaxis and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47(5):1124-1127.
11. Buckwold FJ, Hand R, Hansebout RR. Hospital-acquired bacterial meningitis in neurosurgical patients. J Neurosurg. 1977;46(4):494-500.
12. Spencer MT, Baron BJ. Stenotrophomonas maltophilia meningitis - a rare cause of headache in the ED. Am J Emerg Med. 2001;19(6):532-533.
13. Libanore M, Bicocchi R, Pantaleoni M, et al. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of meningitis. Int J Infect Dis. 2004;8(5):317-319.
14. Lo WT, Wang CC, Lee CM, et al. Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant. Eur J Pediatr. 2002;161(12):680-682.
15. Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000;31(3):705-711.
16. Schaumann R, Stein K, Eckhardt C, et al. Infections caused by Stenotrophomonas maltophilia - a prospective study. Infection. 2001;29(4):205-258.
17. Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis. 1996;22(3):508-512.
18. Rolston KV, Kontoyiannis DP, Yadegarynia D, et al. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbial Infect Dis. 2005;51(3):215-218.
19. Ba BB, Feghali H, Arpin C, et al. Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother. 2004;48(3):946-953.
20. Ooie T, Suzuki H, Terasaki T, et al. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. J Pharmacol Exp Ther. 1996;278(2):590-596.
21. Lutsar I, McCracken G Jr, Friedland I. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis. 1998;27:1117-1129.
22. Modai J. Potential role of fluoroquinolones in the treatment of bacterial meningitis. Eur J Clin Microbiol Infect Dis. 1991;10(4):291-295.
23. Destache CJ, Pakiz CB, Larsen C, et al. Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model. J Antimicrob Chemother. 2001;47(5):611-615.
24. Gogos CA, Maraziotis TG, Papadakis N, et al. Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges. Eur J Clin Microbiol Infect Dis. 1991;10:511-513.
25. Rodriguez-Cerrato V, McCoig CC, Michelow IC, et al. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrob Agents Chemother. 2001;45(11):3092-3097.